Human Nectin-2 / CD112 Protein, His Tag
分子別名(Synonym)
CD112,Nectin-2,PVRL2
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human Nectin-2, His Tag (PV2-H52E2) is expressed from human 293 cells (HEK293). It contains AA Gln 32 - Leu 360 (Accession # Q92692-2).
Predicted N-terminus: Gln 32
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 37.4 kDa. The protein migrates as 45-55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
脊髓灰質(zhì)炎病毒受體相關(guān)2(PVRL2)也被稱為連接蛋白2和CD112(以前是皰疹病毒進(jìn)入介體B,HVEB),它是一種人類質(zhì)膜糖蛋白。PVRL2是粘附分子連接的質(zhì)膜成分之一。PVRL2也是單純皰疹病毒和偽狂犬病病毒某些突變株的入口,它參與了這些病毒的細(xì)胞間傳播。PVRL2基因的變異與多發(fā)性硬化癥嚴(yán)重程度的差異有關(guān)。此外,PVRL2與TIGIT的親和力較低。此外,PVRL2作為單純皰疹病毒1型(HHV-1)突變體Rid1、單純皰疹病毒2型(HHV-2)和偽狂犬病病毒(PRV)的受體。
關(guān)鍵字: Nectin-2;Nectin-2蛋白;Nectin-2重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。